| ²é¿´: 1504 | »Ø¸´: 1 | ||
Ñô¹â@Óê¶½ð³æ (СÓÐÃûÆø)
|
[ÇóÖú]
°ïæ·ÖÎöһϴËҽѧͳ¼Æ·ÖÎöµÄ²»ºÏÀíµÄµØ·½
|
|
ɽ¶«Ê¡ÄþÑôÏØ³ÇÏçÈËȺ¸ßѪѹÊÓÍøÄ¤²¡±äµÄÁ÷Ðв¡Ñ§µ÷²é ÕªÒª£ºÄ¿µÄ Á˽âɽ¶«Ê¡ÄþÑôÏØ³ÇÏçÈËȺÖиßѪѹÊÓÍøÄ¤²¡±ä(hypertensive retinopathy)µÄ»¼²¡ÂÊÐԱ𣬷ÖÎöÆäÏà¹ØÎ£ÏÕÒòËØ¡£·½·¨ ²ÉÓÃÕûÈºËæ»ú³éÑù·½·¨£¬³éÈ¡ÄþÑôÏØ³ÇÇøºÍÅ©´åµÄ35ËêÒÔÉÏÐÂÈ·ÕïΪ¸ßѪѹ²¡µÄ»¼ÕßÒÔ¼°¼ÈÍùÓÐÃ÷È·¸ßѪѹ²¡Ê·µÄ»¼Õß¹²1328È˽øÐÐÎʾíµ÷²é¡¢ÑªÑ¹¼°ÑۿƼì²é¼°¾²ÂöѪʵÑéÊÒ¼ì²â¡£½á¹û 1086Àý£¨81.78£¥£©¸ßѪѹ»¼ÕßÍê³ÉÁËÈ«²¿µÄÎʾíµ÷²é¡¢Ìå¸ñ¼ì²éºÍʵÑéÊÒ¼ì²â¡£ÆäÖÐ313Àý»¼ÕßÑÛµ×Õý³££¬783Àý»¼Õß´æÔÚ²»Í¬³Ì¶ÈµÄ¸ßѪѹÊÓÍøÄ¤²¡±ä£¬Æä»¼²¡ÂÊΪ71.18%£¬ÆäÖТñÆÚ¸ßѪѹÊÓÍøÄ¤²¡±äÕß532Àý£¬¢òÆÚ¸ßѪѹÊÓÍøÄ¤²¡±äÕß159Àý£¬¢óÆÚ¸ßѪѹÊÓÍøÄ¤²¡±äÕß79Àý£¬Î´·¢ÏÖ¢ôÆÚ¸ßѪѹÊÓÍøÄ¤²¡±äÕߣ¬·Ö±ðÔÚ¸ßѪѹ»¼ÕßÖÐÕ¼68.82%£¬20.57%ºÍ10.22%¡£³öÏÖÑÛ²¿²¢·¢Ö¢µÄ¹²53ÈË£¨6.86%£©¡£ÔÚ1086Ãû¸ßѪѹ»¼ÕßÖУ¬ÖªµÀ×Ô¼º»¼¸ßѪѹ²¡±äµÄÕ¼79.1%£¨859ÈË£©£¬Ôø¾½ÓÊÜÒ©ÎïÖÎÁƵÄÕ¼31.5%£¨342ÈË£©¡£Å©´åÈËȺÖиßѪѹÊÓÍøÄ¤²¡±äµÄ»¼²¡ÂÊΪ73.68%£¬³ÇÇøÈËȺÖиßѪѹÊÓÍøÄ¤²¡±äµÄ»¼²¡ÂÊΪ64.82%£¬Ç°ÕßÃ÷ÏÔ¸ßÓÚºóÕß¡£Ó¦¸ÃÊÓΪһ¸öÕûÌåÀ´×Ôͬһ×ÜÌå¸ßѪѹÊÓÍøÄ¤²¡±äµÄ»¼²¡ÂÊËæ×Å»¼ÕßµÄÄêÁ䡢ѪѹֵÒÔ¼°¸ßѪѹ²¡³ÌµÄÔö¼Ó¶øÉý¸ß£¬Ó뻼ÕßµÄÐÔ±ðûÓÐÃ÷ÏÔÏà¹ØÐÔ¡£½áÂÛ ÄþÑôÏØ³ÇÏçÈËȺÖиßѪѹÊÓÍøÄ¤²¡±ä»¼²¡Âʽϸߣ¬ÑªÑ¹¡¢ÄêÁä¡¢³ÇÏç¡¢¸ßѪѹ²¡³ÌµÈÊÇÆäÏà¹ØµÄΣÏÕÒòËØ£¬´æÔÚ¶Ô¼²²¡µÄÖªÏþÂʵ͡¢ÖÎÁÆÂʵÍÇÒ²»¹æ·¶¡¢¿ØÖÆÂʵ͵ÄÇé¿ö¡£½¨Á¢¸ßѪѹÊÓÍøÄ¤²¡±äµÄÁ¢Ìå·ÀÖÎÌåϵÐèÒªÑÛ¿ÆÍ¬ÉçÇø¡¢»ù²ãÒ½ÁÆ»ú¹¹ÒÔ¼°¸÷¼¶ÎÀÉúÔÚ²»Í¬²ãÃæÉϵÄÃÜÇÐÐ×÷¡£ ¡¡¡¡¡¡¹Ø¼ü´Ê£º¸ßѪѹÊÓÍøÄ¤²¡±ä£»»¼²¡ÂÊ£»Î£ÏÕÒòËØ£»Á÷Ðв¡Ñ§ ¡¡¡¡¡¡ÖÐÎÄ·ÖÀàºÅ£º¡¡R 774¡¡ÎÄÏ×±êʶÂ룺A Epidemiological investigation of hypertensive retinopathy in the residents of Ningyang county in Shandong province Abstract£ºObjective To study the morbidity of hypertensive retinopathy in the residents of the Ningyang county in Shandong province and analyze its related risk factors£®Methods Totally 1328 hypertension patients aged ¡Ý 35 years in ningyang were selected by cluster random sampling method and investigated with questionnaire survey, physical examination and venous blood test. Results 1086(81.78%) hypertension patients completed all of the questionnaire, physical examination and laboratory detection. There were 313 cases with normal retinal ,and 783 cases with hypertensive retinopathy in varying degrees,including 532 cases of grade¢ñ(68.82%),159 cases of grade ¢ò(20.57%),79 cases of grade ¢ó (10.22%)and none of grade ¢ô£¬and only 53 cases occurred ocular complications (6.86%).The morbidity of hypertensive retinopathy in ningyang was 71.18%. 859 cases knew that they were suffering from high blood pressure diseases (79.1%), and 342 people had been treated with drug therapy (31.5%). The morbidity of hypertensive retinopathy in the rural residents was 73.68%, which is clearly higher than that in county residents ( 64.82%). With the increase of the patient's age, blood pressure value and the course of the disease , the morbidity of hypertensive retinopathy was increased, but there was no significant correlation with the sex of the patients. Conclusion The morbidity of hypertensive retinopathy in Ningyang was relatively high. The risk factors included blood pressure, age, residential area £¬the course of hypertension. And it was characterized with Low awareness rate , low treatment rate and low control rate. Ophthalmologists need to cooperate closely with the medical institutions at all levels to establish the prevention and control system of hypertensive retinopathy. Key words : hypertensive retinopathy£» morbidity£» risk factor£» Epidemiology ¡¡¡¡¡¡ ¡¡¡¡¡¡¡¡¸ßѪѹÊÇ×î³£¼ûµÄÐÄѪ¹Ü¼²²¡,ÊǹÚÐIJ¡ºÍÄÔѪ¹Ü²¡µÄÖ÷ҪΣÏÕÒòËØ [1¡«2],¸ßѪѹ»¼ÕßÊÓÍøÄ¤¾Ö²¿µÄÌØÕ÷ÐÔ²¡±ä,·´Ó³Á˸ßѪѹ¶Ô°ÐÆ÷¹ÙµÄË𺦳̶È,ÇÒÆä²¡±ä³Ì¶ÈÓëÈ«ÉíÖ÷ÒªÔàÆ÷²¡±ä³Ì¶È³ÊÕýÏà¹Ø,²¢ÇÒÊÇÔçÓÚÆäËû¸÷²¢·¢Ö¢µÄÁÙ´²±íÏÖ£¬¶øÇÒÊÓÍøÄ¤Ñª¹ÜÊÇÈËÌåΨһ¿ÉÒÔͨ¹ý²»ÇÖÈëµÄ·½·¨Ö±½Ó¹Û²ìµ½µÄµÄѪ¹Ü,Æä²¡±ä¿É¼ä½Ó·´Ó³ÐÄ¡¢ÄÔ¡¢ÉöµÈѪ¹Ü²¡±äÇé¿ö, ±»ÈÏΪÊÇÆÀ¼ÛÐÄÄÔѪ¹ÜÒâÍâΣÏÕÐÔµÄÖØÒªÖ¸±ê[3¡«4] ¡£±¾Ñо¿ÔÚÃèÊöÄþÑôÏØ³ÇÏçÈËȺµÄ¸ßѪѹÊÓÍøÄ¤²¡±äµÄÁ÷Ðв¡Ñ§·Ö²¼ÌØÕ÷µÄ»ù´¡ÉÏ£¬Ñ°ÕÒÆä¿ÉÄܵÄΣÏÕÒòËØ£¬Îª½øÒ»²½Ïà¹ØÑо¿ÌṩÁ÷Ðв¡Ñ§»ù´¡¼°¿Í¹ÛÒÀ¾Ý¡£ 1¡¡¶ÔÏóÓë·½·¨ 1. 1¡¡¶ÔÏó ¡¡¡¡¡¡²ÉÈ¡Ëæ»úÕûȺ³éÑù£¨ÏÞ¶¨ÈËȺÕûȺ³éÑù£©·½·¨½øÐгéÑù, ÒÔ³ÇÇø¸÷ÉçÇø»òÏçÕò¸÷Å©´åΪ»ù±¾³éÑùµ¥Î», ³éÈ¡³ÇÇøÄÚ2¸öÉçÇøºÍ8¸öÅ©´åΪµ÷²éµã£¬Ã¿¸öµ÷²éµ¥Î»Æ½¾ùµ÷²é100¡«200Ãû¸ßѪѹ»¼Õߣ¨°üÀ¨ÐÂÈ·ÕïΪ¸ßѪѹ²¡µÄ»¼ÕßÒÔ¼°¼ÈÍùÓÐÃ÷È·¸ßѪѹ²¡Ê·µÄ»¼Õߣ©£¬¹²1328ÈË£¬ÄêÁä35Ëê¡«89Ëê,ÆäÖÐÄÐÐÔ556ÈË£¬Å®ÐÔ772ÈË¡£ 1. 2¡¡µ÷²é²½Öè¼°·½·¨ ¡¡¡¡¡¡Ô¤µ÷²é½×¶Î: 2009Äê10¡«12Ô¡£´Ë½×¶ÎÖ÷ÒªÊÇÓëµ±µØÕþ¸®¼°Ïà¹Ø×éÖ¯»ú¹¹ÁªÏµÐÉÌ,¶Ô³éÈ¡µÄ´åµÄ¾ÓÃñ½øÐÐͳ¼ÆÓëԤԼ֪ͨ¡£ÔÚÕýʽµ÷²é¿ªÊ¼Ç°,½øÐÐÁË1ÖܵÄÏà¹ØÅàѵ¡¢Ô¤µ÷²é¡£ ¡¡¡¡¡¡µ÷²é½×¶Î:ÏÖ³¡¹¤×÷ʱ¼äΪ2010Äê3Ô¡«10Ô¡£µ÷²é¹¤×÷ÓÉÒ»¸ö¹¤×÷×é½øÐÐ,ÓÉ3Ãû¸ßÄê×ÊÑÛ¿ÆÒ½Ê¦¡¢Ïà¹ØÐÐÕþÈËÔ±¡¢¸÷ÎÀÉúÔºÒ½ÎñÈËÔ±µÈ×é³É,ÆäÖÐ2ÃûÑÛ¿ÆÖ÷ÈÎҽʦ¸ºÔðÖÊÁ¿¿ØÖÆ¡£µ÷²éµØµãÒÔ¸÷³ÇÏçÎÀÉúԺΪÖ÷,¶Ô¸ö±ðÐж¯²»±ãÕßµ÷²éÈËԱǰÍùÈë»§µ÷²é¡£ÎªÁ˱£Ö¤¼ì²é·½·¨ºÍ¼ì²é½á¹û¿É¿¿, ËùÓмì²é¾ùÓɹ̶¨ÑÛ¿ÆÒ½Ê¦½øÐС£ 1. 3¡¡Õï¶Ï±ê×¼ 1. 3.1¸ßѪѹ²¡Õï¶Ï°´¡¶Öйú¸ßѪѹ·ÀÖÎÖ¸ÄÏ¡·[5] £¬ÊÕËõѹ¡Ý 140mmH g ºÍ£¨»ò£©ÊæÕÅѹ¡Ý 90mmHg¡£ 1. 3.2¸ßѪѹÑ۵׸ıäÕï¶ÏÒÔKeith¡ªWagenerÊÏ·Ö¼¶·¨ÎªÒÀ¾Ý:¢ñ¼¶:ÊÓÍøÄ¤Ð¡¶¯Âö·´¹â´ø¼Ó¿í,¹Ü¾¶²»¹æÔò,¶¯¾²Âö½»²æÑ¹¼£²»Ã÷ÏÔ£»¢ò¼¶:¶¯Âö¹â´ø¼Ó¿í,³Ê¸Ö˿״»òÒøË¿×´Íâ¹Û,¶¯¾²Âö½»²æ´¦ÓÐÃ÷ÏÔѹ¼£,ÊÓÍøÄ¤¿É¼ûÓ²ÐÔÉø³ö£»¢ó¼¶:¶¯Âö¹Ü¾¶Ã÷ÏÔ±äϸ,ÊÓÍøÄ¤Ë®Ö×,ÓÐÃÞÈÞ°ß¼°Æ¬×´³öѪ£»¢ô¼¶:ÔÚ¢ó¼¶Ñª¹Ü¸Ä±äºÍÊÓÍøÄ¤±ä»¯µÄ»ù´¡ÉÏ,·¢ÉúÊÓÈéÍ·Ë®Öס£ 4¡¡µ÷²éÄÚÈÝ ¢Ù»¼ÕßѪѹ£¬Éí¸ß£¬ÌåÖØµÈ£¬Ã¿¸ö¸öÌå¾ù²âÁ¿3´ÎѪѹ, È¡3´ÎѪѹµÄ¾ùֵΪ¸Ã¸öÌåѪѹˮƽ£¬¢ÚÎʾíµ÷²é£ºÎʾíÄÚÈݰüÀ¨Ò»°ãÇé¿ö£¨ÐÕÃû£¬ÐÔ±ð£¬ÄêÁ䣬ÒûʳÉú»îϰ¹ßµÈ£©£¬¸ßѪѹ²¡²¡Ê·¡¢¼Ò×åÊ·¡¢ÖÎÁÆÇé¿ö¼°ÑªÑ¹¿ØÖÆÇé¿ö£¬ÑÛ²¿¼²²¡Ê·£¬ÌÇÄò²¡¼°¸ßѪ֢֬µÈ¼²²¡Ê·µÈ¡£¢ÛÑۿƼì²é£ºÂãÑÛÔ¶ÊÓÁ¦£»ÁÑ϶µÆ¼ì²é½áĤ¡¢½ÇĤ¡¢Ç°·¿¡¢ºçĤ¡¢¾§Ì弰ǰ¶Ë²£Á§Ì壻·Ç½Ó´¥ÑÛѹ¼Æ½øÐÐÑÛѹ²âÁ¿£»¾¸´·½ÍÐßÁ¿¨°·µÎÑÛҺɢͫºóÓÃVOLK 90DǰÖþµ¼ì²é»¼ÕßÑÛµ×ÈçÊܼìÕßǰ·¿Ç³ÔòСͫ¿×ÏÂÓÃÖ±½ÓÑÛµ×¾µ¼ì²éÑÛµ×£»¶ÔÓÚË«ÑÛÇü¹â¼äÖÊÇåÎúÕß¾ù¸øÓè¼ì²éË«ÑÛ£¬Ë«ÑÛÑ۵ײ¡±ä³Ì¶È²»Í¬Õߣ¬¼Ç¼²¡±äÏà¶Ô½ÏÖØµÄÒ»ÑÛ£¬¶ÔÓÚÒ»ÑÛ´æÔÚÑÏÖØ°×ÄÚÕÏ»ò²£Á§Ìå»ì×ÇÕߣ¬¼Ç¼ÁíÒ»ÑÛÑÛµ×£»¼ì²éҽʦÏêϸ¡¢Í³Ò»µÄ¼Ç¼¼ì²é½á¹û£¬¶ÔÁÙ´²±íÏÖ¿ÉÒÉÕß,ÓÉËùÓмì²éҽʦ¹²Í¬¼ì²éºóÅжϡ£¢Ü²É¼¯¿Õ¸¹¾²ÂöѪ¼à²âѪÌǼ°ÑªÖ¬¡£ 1. 5 ͳ¼ÆÑ§·½·¨ ²ÉÓÃSPSS 13. 0ͳ¼ÆÑ§Èí¼þ½øÐÐͳ¼ÆÑ§´¦Àí,¶ÔÓÚÁ½¸öÑù±¾»¼²¡ÂʵıȽÏÓ¦ÓÃËĸñ±í×ÊÁÏX2¼ìÑ飬¶ÔÓÚͬһ²ÎÊý¸÷×黼²¡ÂʼäµÄ±È½ÏÓ¦ÓÃX2Ç÷ÊÆ¼ìÑ飬¼ìÑéµÄÏÔÖøÐÔÈ¡¦Á=0.01£¬P<0.01ÓÐÏÔÖøÐÔ²îÒì¡£¼ì²é½á¹ûÓÉרÈËרÏîÌî±í,ÊÕ¼¯µÄÊý¾Ý¾2ÈË2´ÎÖØ¸´ÊäÈë¼ÆËã»úÒÔ±£Ö¤×¼È·ÐÔ¡£ 2¡¡½á¹û ¡¡¡¡¡¡±¾µ÷²éʵ¼ÊÊܼìÕßΪ1328Àý£¬ÆäÖÐ242ÀýÓÉÓڼǼ×ÊÁϲ»È«Î´°üÀ¨ÔÚͳ¼Æ½á¹ûÖС£1086ÀýÊܼìÕßÍê³ÉÁËÈ«²¿ÎÊ¾í¼°¼ì²é,ÆäÖÐÄÐÐÔ446£¨41.07%£©,Å®ÐÔ640Àý£¨58.93%£©,ÄÐÅ®±ÈÀýΪ1£º1.43£»ÄêÁä35¡«89Ëê,ƽ¾ù57.85Ëꣻ1086ÀýÊܼìÕßÖÐ303ÀýÑÛµ×Õý³££¬783Àý³öÏÖ²»Í¬³Ì¶ÈµÄ¸ßѪѹÊÓÍøÄ¤²¡±ä£¬¸ßѪѹÊÓÍøÄ¤²¡±äµÄ»¼²¡ÂÊΪ72.10%£¬ÆäÖТñÆÚ531Àý£¬¢òÆÚ177Àý£¬¢óÆÚ75Àý£¬Ã»Óз¢ÏÖ¢ôÆÚ»¼Õߣ¬·Ö±ðÕ¼67.82%£¬22.60%¼°9.58%£¨Èç±í1£©¡£ÄÐÐÔ»¼²¡ÂÊΪ73.32%£¬Å®ÐÔ»¼²¡ÂÊΪ71.25%£¬Á½ÕßûÓÐÃ÷ÏÔͳ¼ÆÑ§²îÒ죨P£¾0.01£©£¨Èç±í2£©¡£ ¡¡¡¡¡¡1086ÀýÊܼìÕßÖÐÅ©´åÈËȺ779Àý£¨ÄÐÐÔ310Àý£¬Å®ÐÔ469Àý£©£¬´æÔÚ¸ßѪѹÊÓÍøÄ¤²¡±äµÄΪ581Àý£¬»¼²¡ÂÊΪ74.58%£»³ÇÇøÈËȺ307Àý£¬´æÔÚ¸ßѪѹÊÓÍøÄ¤²¡±äµÄΪ202Àý£¬»¼²¡ÂÊΪ65.80%£»Å©´åÈËȺ¸ßѪѹÊÓÍøÄ¤²¡±äµÄ·¢²¡ÂÊÃ÷ÏÔ¸ßÓÚ³ÇÇøÈËȺ£¬Á½Õß´æÔÚͳ¼ÆÑ§²îÒ죨P£¼0.01£©£¨Èç±í1£©¡£35¡«45ËêÊܼìÕß127ÀýÖÐ72Àý´æÔÚ¸ßѪѹÊÓÍøÄ¤²¡±ä£¬45¡«55ËêÊܼìÕß109ÀýÖÐ72Àý´æÔÚ¸ßѪѹÊÓÍøÄ¤²¡±ä£¬55¡«65ËêÊܼìÕß325ÀýÖÐ232Àý´æÔÚ¸ßѪѹÊÓÍøÄ¤²¡±ä£¬65¡«75ËêÊܼìÕß428ÀýÖÐ325Àý´æÔÚ¸ßѪѹÊÓÍøÄ¤²¡±ä£¬75Ëê¼°ÒÔÉϵÄÊܼìÕß97Àý£¬ÆäÖдæÔÚ¸ßѪѹÊÓÍøÄ¤²¡±äµÄ82Àý£¬ÒÔÉÏÎå¸ö²»Í¬ÄêÁä¶ÎÊܼìÕߵĸßѪѹÊÓÍøÄ¤²¡±ä»¼²¡ÂÊ·Ö±ðΪ56.69%£¬66.06%£¬71.38%£¬75.93%ºÍ84.54%£¬±íÃ÷´æÔÚËæ×ÅÄêÁäÔö¼Ó¸ßѪѹÊÓÍøÄ¤²¡±ä»¼²¡ÂÊÔö¼ÓµÄÇ÷ÊÆ£¬ÓÐͳ¼ÆÑ§ÒâÒ壨P£¼0.01£©£¨Èç±í3£©¡£ ¡¡¡¡¡¡ÊܼìÕßÖÐÊÕËõѹСÓÚ140mmHgµÄ102ÈË£¬ÆäÖÐ49Àý´æÔÚ²»Í¬³Ì¶ÈµÄÑ۵׸ı䣬»¼²¡ÂÊΪ48.04%£¬ÊÕËõѹÔÚ140¡«160mmHgÖ®¼äµÄ496Àý£¬ÆäÖÐ338Àý´æÔÚÑ۵׸ı䣬»¼²¡ÂÊΪ68.15%£¬ÊÕËõѹÔÚ160¡«180mmHgµÄ409Àý£¬ÆäÖÐ318Àý´æÔÚÑ۵׸ı䣬»¼²¡ÂÊΪ77.75%£¬ÊÕËõѹ´óÓÚµÈÓÚ180mmHgµÄ79Àý£¬ÓÐ78Àý´æÔÚÑ۵׸ı䣬»¼²¡ÂÊΪ98.73%£¬½á¹û±íÃ÷´æÔÚËæ×Å»¼ÕßÊÕËõѹÔö¼Ó¸ßѪѹÊÓÍøÄ¤²¡±ä»¼²¡ÂÊÔö¼ÓµÄÇ÷ÊÆ£¨P£¼0.01£©£¨Èç±í4£©¡£ÊܼìÕßÖÐÊæÕÅѹСÓÚ90mmHgµÄ234Àý£¬ÆäÖÐ64Àý´æÔÚ²»Í¬³Ì¶ÈµÄÑ۵׸ı䣬»¼²¡ÂÊΪ27.35%,ÊÕËõѹÔÚ90¡«110mmHgµÄ511Àý£¬ÆäÖÐ407Àý´æÔÚÑ۵׸ı䣬»¼²¡ÂÊΪ79.65%£¬ÊÕËõѹÔÚ110¡«130mmHgµÄ299Àý£¬ÆäÖÐ270Àý´æÔÚÑ۵׸ı䣬»¼²¡ÂÊΪ90.30%£¬ÊÕËõѹ´óÓÚµÈÓÚ130mmHgµÄ42ÀýÈ«²¿´æÔÚÃ÷ÏÔµÄÑ۵׸ı䣬»¼²¡ÂÊΪ100%£¬±íÃ÷´æÔÚËæ×Å»¼ÕßÊæÕÅѹÉý¸ßÆä¸ßѪѹÊÓÍøÄ¤²¡±äµÄ»¼²¡ÂÊÔö¼ÓµÄÇ÷ÊÆ£¨P£¼0.01£©£¨Èç±í5£©¡£ ¡¡¡¡¡¡Ñо¿Í¬Ê±±íÃ÷¸ßѪѹ²¡³ÌÓë¸ßѪѹÊÓÍøÄ¤²¡±äµÄ·¢Éú´æÔÚÒ»¶¨Ïà¹ØÐÔ£¬´æÔÚ²¡³ÌÔ½³¤¸ßѪѹÊÓÍøÄ¤²¡±ä»¼²¡ÂÊÔ½¸ßµÄÇ÷ÊÆ£¨P£¼0.01£©£¨Èç±í6£©£º²¡³ÌСÓÚ1ÄêµÄÊܼìÕß73Àý£¬ÆäÖÐ19Àý´æÔÚÑ۵׸ı䣬¼ì³öÂÊΪ26.03%£¬²¡³ÌÔÚ1¡«5ÄêÖ®¼äµÄ201ÀýÖÐ70Àý´æÔÚÑ۵׸ı䣬»¼²¡ÂÊΪ34.83%£¬²¡³ÌÔÚ5¡«10ÄêÖ®¼äµÄ299ÀýÖÐ201Àý´æÔÚÑ۵׸ı䣬»¼²¡ÂÊΪ67.22%£¬²¡³ÌÔÚ10¡«15ÄêÖ®¼äµÄ199ÀýÖÐ179Àý´æÔÚÑ۵׸ò¡£¬»¼²¡ÂÊΪ89.95%£¬²¡³ÌÔÚ15¡«20ÄêÖ®¼äµÄ203Àý¼°²¡³Ì20Äê¼°ÒÔÉϵÄ111ÀýÈ«²¿´æÔÚÃ÷ÏÔµÄÑ۵׸ı䡣ÊܼìµÄ783Àý¸ßѪѹÊÓÍøÄ¤²¡±ä»¼ÕßÖÐÓÐ53È˳öÏÖÑÛ²¿²¢·¢Ö¢£¨6.77%£©£¬ÆäÖÐÊÓÍøÄ¤¶¯Âö×èÈûµÄ2ÈË£¬ÊÓÍøÄ¤¾²Âö×èÈûµÄ5ÈË£¬ÊÓÍøÄ¤Ç°Ä¤9ÈË£¬»Æ°ß±äÐÔÕß34ÈË£¬ÊÓÍøÄ¤¾²Âö˨²¢·¢ÐÂÉúѪ¹ÜÐÔÇà¹âÑÛµÄ1ÈË£¬²£Á§Ìå»ýѪÕß2ÈË¡£ ÔÚÊܼìµÄ1086Ãû¸ßѪѹ»¼ÕßÖУ¬ÖªµÀ×Ô¼º»¼¸ßѪѹ²¡±äµÄÕ¼79.1%£¨859ÈË£©£¬Ôø¾½ÓÊÜÒ©ÎïÖÎÁƵÄÕ¼31.49%£¨342ÈË£©£¬ÆäÖнöÓÐ79È˲»Í¬³Ì¶ÈÖªÏþ¸ßѪѹÊÓÍøÄ¤²¡±ä£¨7.27%£©¡£ ±í1£ºÄþÑôÏØ³ÇÏçÈËȺ²»Í¬·ÖÆÚ¸ßѪѹÊÓÍøÄ¤²¡±ä»¼²¡ÂÊ Fig1£ºThe morbidity of hypertensive retinopathy in county and rural population of Ningyang Çø Óò Õý³£ ¡¡ ¢ñÆÚ ¡¡ ¢òÆÚ ¡¡ ¢óÆÚ ¡¡ HR£¨¸÷ÆÚ ºÏ¼Æ£© ×Ü ÈË Êý ÀýÊý °Ù·Ö ±È% ¡¡ ÀýÊý °Ù·Ö ±È% ¡¡ ÀýÊý °Ù·Ö ±È% ¡¡ ÀýÊý °Ù·Ö ±È% ¡¡[Êܼì²éÈËÊýµÄ¹¹³É±È£¬Ó¦¸ÄΪÊܼìÈËÊý+¼ì³öÒì³£ÈËÊýµÄ»¼²¡¼ì³öÂÊ] ÀýÊý HR»¼ ²¡ÂÊ% Å© ´å 198 25.42 384 49.29 140 17.97 57 7.32 581 74.58 779 ³Ç Çø 105 34.20 147 47.88 37 12.05 18 5.86 202 65.80 307 ºÏ ¼Æ 303 27.90 ¡¡ 531 48.90 ¡¡ 177 16.30 ¡¡ 75 6.91 ¡¡ 783 72.10 1086 ¡¡¡¡±í2 ÄþÑôÏØ³ÇÏçÈËȺ²»Í¬ÐÔ±ð¸ßѪѹÊÓÍøÄ¤²¡»¼²¡ÂÊ ¡¡¡¡Fig2£ºThe morbidity of hypertensive retinopathy of different sex in Ningyang ÐÔ±ð Õý³£ ¡¡ ¢ñÆÚ ¡¡ ¢òÆÚ ¡¡ ¢óÆÚ ¡¡ HR£¨¸÷ÆÚ ºÏ¼Æ£© ×Ü ÈË Êý ÀýÊý °Ù·Ö ±È% ¡¡ ÀýÊý °Ù·Ö ±È% ¡¡ ÀýÊý °Ù·Ö ±È% ¡¡ ÀýÊý °Ù·Ö ±È% ¡¡ ÀýÊý HR»¼ ²¡ÂÊ% ÄÐ 119 26.68 219 49.10 79 17.71 29 6.50 327 73.32 446 Å® 184 28.75 312 48.75 98 15.31 46 7.19 456 71.25 640 ºÏ¼Æ 303 27.90 ¡¡ 531 48.90 ¡¡ 177 16.30 ¡¡ 75 6.91 ¡¡ 783 72.10 1086 ¡¡¡¡¡¡ ¡¡¡¡±í3 ÄþÑôÏØ³ÇÏçÈËȺ¸÷ÄêÁä½×¶Î¸ßѪѹÊÓÍøÄ¤²¡±ä»¼²¡ÂÊ ¡¡¡¡Fig3£ºThe morbidity of hypertensive retinopathy of different age groups in Ningyang ÄêÁ䣨Ë꣩ ¡Ý35 ¡Ý45 ¡Ý55 ¡Ý65 ¡Ý75 ºÏ¼Æ ÊܼìÈËÊý 127 109 325 428 97 1086 HR»¼Õß 72 72 232 325 82 783 HR»¼²¡ÂÊ 56.69% 66.06% 71.38% 75.93% 84.54% 72.10% ±í4 ÄþÑôÏØ³ÇÏçÈËȺ²»Í¬ÊÕËõѹ»¼ÕߵĸßѪѹÊÓÍøÄ¤²¡±ä»¼²¡ÂÊ Fig4£ºThe morbidity of hypertensive retinopathy of different systolic pressure groups in Ningyang ÊÕËõѹ £¼140mmHg ¡Ý140mmHg ¡Ý160mmHg ¡Ý180mmHg ºÏ¼Æ ÊܼìÈËÊý 102 496 409 79 1086 HR»¼Õß 49 338 318 78 783 HR»¼²¡ÂÊ 48.04% 68.15% 77.75% 98.73% 72.10% ±í5 ÄþÑôÏØ³ÇÏçÈËȺ²»Í¬ÊæÕÅѹ»¼ÕߵĸßѪѹÊÓÍøÄ¤²¡±ä»¼²¡ÂÊ Fig5£ºThe morbidity of hypertensive retinopathy of different diastolic pressure groups in Ningyang ÊæÕÅѹ £¼90mmHg ¡Ý90mmHg ¡Ý110mmHg ¡Ý130mmHg ºÏ¼Æ ÊܼìÈËÊý 234 511 299 42 1086 HR»¼Õß 64 407 270 42 783 HR»¼²¡ÂÊ 27.35% 79.65% 90.30% 100.00% 72.10% ¡¡¡¡¡¡ ±í6 ÄþÑôÏØ³ÇÏçÈËȺ²»Í¬¸ßѪѹ²¡³Ì»¼Õ߸ßѪѹѹÊÓÍøÄ¤²¡±ä»¼²¡ÂÊ Fig6£ºThe morbidity of hypertensive retinopathy of different course of hypertension in Ningyang ²¡³Ì £¼1Äê ¡Ý1Äê ¡Ý5Äê ¡Ý10Äê ¡Ý15Äê ¡Ý20Äê ºÏ¼Æ ÊܼìÈËÊý 73 201 299 199 203 111 1086 HR»¼Õß 19 70 201 179 203 111 783 HR»¼²¡ÂÊ 26.03% 34.83% 67.22% 89.95% 100.00% 100.00% 72.10% 3 ÌÖ ÂÛ ¡¡¡¡¡¡¸ßѪѹÊÇ×î³£¼ûµÄÈ«ÉíÐÔ¼²²¡,ÊÇÐÄÄÔѪ¹Ü¼²²¡µÄÖ÷ҪΣÏÕÒòËØ£¬ 2010°æ¡¶Öйú¸ßѪѹ·ÀÖÎÖ¸ÄÏ¡·ÖÐÖ¸³öÎÒ¹úÿ5¸ö³ÉÈËÖоÍÓÐ1ÈË»¼¸ßѪѹ£¬Ä¿Ç°È«¹ú¸ßѪѹ»¼ÕßÖÁÉÙ2ÒÚ£¬µ«¸ßѪѹ֪ÏþÂÊ¡¢ÖÎÁÆÂʺͿØÖÆÂʽϵͣ¬´Ó¶ø³öÏÖÑÏÖØµÄ²¢·¢Ö¢£¬ÊÇΣº¦¹úÃñ½¡¿µµÄ×îÖ÷Òª¼²²¡Ö®Ò»¡£¸ßѪѹÒýÆðÊÓÍøÄ¤Ñª¹ÜµÄ²¡ÀíÐԸıäÊÇÈ«ÉíÐÔѪ¹Ü²¡±äµÄÒ»²¿·Ö, ÆäËùÖÂÊÓÍøÄ¤Ñª¹ÜµÄ¸Ä±ä»ù±¾ÉÏÓë¸ßѪѹ¸÷ʱÆÚµÄ±ä»¯ÏàÒ»ÖÂ,ÔÚÒ»¶¨³Ì¶ÈÉÏÄÜ·´Ó³ÌåÄÚ¶¯ÂöµÄÇé¿ö, ÔÚ¸ßѪѹ³õÆÚÊÓÍøÄ¤Ñª¹ÜÍùÍùÊÇÕý³£µÄ,Ëæ×ÅѪѹµÄÉý¸ßºÍ²¡³ÌµÄÑÓ³¤,ÊÓÍøÄ¤Ñª¹Ü90% Öð½¥·¢ÉúһϵÁйܾ¶ºÍ¹Ü±ÚµÄ¸Ä±ä,ÐγÉÌØÕ÷ÐÔµÄÊÓÍøÄ¤²¡±ä¡£´ËÍ⣬ÊÓÍøÄ¤Ñª¹ÜÊÇÈËÌåΨһ¿ÉÒÔ½èÖú¼ìÑÛ¾µÖ±½Ó¹Û²ìµ½µÄѪ¹Ü,ͨ¹ý¹Û²ì¸ßѪѹ»¼ÕßµÄÊÓÍøÄ¤µÄÌØÕ÷ÐÔ²¡±ä,¿ÉÒÔ·´Ó³¸ßѪѹ¶ÔÆäËû°ÐÆ÷¹ÙµÄË𺦳̶ȣ¬¶ÔÅжϸßѪѹ²¡µÄÑÏÖØ³Ì¶ÈºÍÔ¤ºóÓÐÒ»¶¨µÄ¼ÛÖµ¡£ËùÒÔ£¬½øÐиßѪѹÊÓÍøÄ¤²¡±äµÄÁ÷Ðв¡Ñ§µ÷²é£¬Á˽âÆä»¼²¡ÂʺÍÏà¹ØÎ£ÏÕÒòËØ£¬¶ÔÓÚ¸ßѪѹÊÓÍøÄ¤²¡±ä¼°¸ßѪѹµÄ·ÀÖι¤×÷¶¼¾ßÓÐÖØÒªÒâÒ塣ĿǰÓйؼ²²¡µÄÁ÷Ðв¡Ñ§µ÷²éµÄÖ÷ÒªÓÐÁ½ÖÖ·½Ê½£ºÒ»ÖÖÊÇÒÔ¸÷²ãÒ½ÔºµÄ»¼ÕßΪµ÷²é¶ÔÏó£¬ËüÈÝÒ××éÖ¯¡¢×ÊÁÏÆëÈ«¡¢Ê¡Ê±¡¢·ÑÓýϵͣ¬µ«ÊÇ»ñµÃµÄ»¼²¡ÂÊÆ«¸ß£»ÁíÒ»ÖÖÊÇÒÔÏÞ¶¨µÄ×ÔÈ»ÈËȺΪµ÷²é¶ÔÏó£¬Ëü×éÖ¯¹æÄ£½Ï´ó£¬ºÄ·Ñ¾Þ´óÈËÁ¦¡¢²ÆÁ¦£¬µ«ËùµÃÊý¾ÝÕæÊµ£¬¿ÉÒÔ·´Ó³ÈËȺµÄÕæÊµ»¼²¡Çé¿ö¡£Ëù[¿Éɾ]ÒÔ£¬ÎÒÃÇ´Ë´Îͨ¹ýÓëͬɽ¶«Ê¡¼²²¡Ô¤·À¿ØÖÆÖÐÐÄÃÜÇкÏ×÷£¬¶Ôɽ¶«Ê¡ÄþÑôÏØ³ÇÏç×ÔÈ»ÈËȺÖиßѪѹÊÓÍøÄ¤²¡±äµÄ»¼²¡ÂʽøÐÐÁ˵÷²é£¬²¢·ÖÎöÆäÏà¹ØÎ£ÏÕÒòËØ£¬ÎªÒÔºó¸ü´óÈËȺµÄµ÷²éµì¶¨»ù´¡£¬Ò²ÎªÎÒÊ¡µÄ·ÀäÖÎ乤×÷ÌṩÁËÒ»¶¨ÒÀ¾Ý¡£ ¡¡¡¡¡¡¡¡´Ë´Îµ÷²éÏÔʾɽ¶«Ê¡ÄþÑôÏØ³ÇÏçÈËȺ¸ßѪѹÊÓÍøÄ¤²¡±äµÄ»¼²¡ÂÊΪ72.10%£¬ÆäÖиßѪѹÊÓÍøÄ¤²¡±ä¢ñÆÚ¡¢¢òÆÚ¡¢¢óÆÚ»¼²¡¹¹³É±ÈΪ67.82%£¬22.60%¼°9.58%£¬Ã»Óз¢ÏÖ¢ôÆÚ»¼Õߣ¬ÆäÖÐÓÐ53È˳öÏÖѪ¹Ü˨Èû£¬²£Á§Ìå³öѪ£¬ÊÓÍøÄ¤Ç°Ä¤µÈÏà¹Ø²¢·¢Ö¢£¬ÓëÏà¹ØÎÄÏ×±¨µÀµÄÎÒ¹ú¸ßѪѹÐÔÊÓÍøÄ¤²¡±ä»¼²¡ÂÊ70%×óÓÒ£¬ÇÒÒÔÇá¶Èµ½ÖжȲ¡±äÕ߾Ӷ࣬»ù±¾Ïà·û[6]¡£1960ÄêÕųзҵÈÑо¿1000ÀýÔ·¢ÐÔ¸ßѪѹ»¼ÕߵĸßѪѹÊÓÍøÄ¤²¡±ä»¼²¡ÂÊΪ64.7%[7]£¬1965Äê»ÆÊåÈʵÈÑо¿1000ÀýÔ·¢ÐÔ¸ßѪѹ»¼ÕߵĸßѪѹÐÔÊÓÍøÄ¤²¡±ä»¼²¡ÂÊΪ66%[8]£¬2001Ä꽪ÊçÓ¢µÈ¶Ô600ÀýÔ·¢ÐÔ¸ßѪѹ»¼ÕßÑо¿£¬Æä¸ßѪѹÐÔÊÓÍøÄ¤²¡±ä»¼²¡ÂÊΪ77%[9]£¬½áºÏ±¾´ÎÑо¿72.10%µÄ»¼²¡ÂÊ£¬Ëƺõ±íÃ÷ÎÒ¹ú¸ßѪѹÊÓÍøÄ¤²¡±äµÄ»¼²¡ÂÊÓÐÉý¸ßµÄÇ÷ÊÆ£¬Õâ¿ÉÄÜÊÇËæ×ÅÎÒ¹ú¾¼ÃÌõ¼þµÄ¸ÄÉÆ£¬ÈËÃñÉú»î·½Ê½ÓÐÁ˽ϴóµÄ¸Ä±ä£¬Òûʳ½á¹¹µÄ¸Ä±ä£¬Éú»î½Ú×àµÄ¼Ó¿ì£¬¸öÈËÓ¦¼¤¸ººÉµÄÔö¼Ó£¬ÄÔÁ¦ÀͶ¯µÄÔö¼Ó£¬Ô˶¯µÄ¼õÉÙÒÔ¼°»·¾³µÄ¸Ä±äµÈÒòËØÖÂʹ¾ÓÃñµÄ¸ßѪѹ»¼²¡ÂÊÖðÄêÉý¸ßÓйء£ ±¾Ñо¿½á¹ûÏÔʾũ´åÈËȺ¸ßѪѹÊÓÍøÄ¤²¡±ä»¼²¡ÂÊΪ74.58%£¬³ÇÇøÈËȺ¸ßѪѹÊÓÍøÄ¤²¡±ä»¼²¡ÂÊΪ65.80%£¬Ç°ÕßÃ÷ÏÔ¸ßÓÚºóÕߣ¬¿ÉÄÜÊÇÒòΪũ´åÈËȺ´æÔÚ¸üÃ÷ÏÔµÄÉÅʳ¸ßÑκÍÒûʳ½á¹¹²»ºÏÀí¡¢¹ýÁ¿Òû¾Æ£¬´óÁ¿ÎüÑÌ¡¢ÌåÁ¦»î¶¯¼õÉÙµÈÇé¿ö£¬Í¬Ê±½¡¿µÖªÊ¶Ë®Æ½¸üµÍ£¬¶Ô¸ßѪѹÈÏʶ²»¹»È«Ã棬²»Ö÷¶¯È¥Ò½Ôº×÷½¡¿µÌå¼ì£¬·¢ÏÖ¼²²¡±È½ÏÍí£¬¶øÇҴ󲿷ֻ¼Õß¼´Ê¹ÖªµÀ×Ô¼º»¼ÓиßѪѹ²¡ÓÖ²»¼°Ê±¹æ·¶ÖÎÁÆ£¬Ò»°ãÊDz»ÄÑÊܲ»³ÔÒ©£¬Òò¶ø²»ÄܺܺÿØÖÆÑªÑ¹µÈµÈÓйء£ ¡¡¡¡¡¡±¾Ñо¿±íÃ÷¸ßѪѹÊÓÍøÄ¤²¡±äµÄ·¢ÉúÓ뻼ÕßµÄѪѹ³Ì¶È¼°¸ßѪѹ²¡³ÌÓÐÒ»¶¨Ïà¹ØÐÔ£¬Ëæ×Å»¼ÕßµÄѪѹ£¨ÊÕËõѹ»òÊæÕÅѹ£©Ôö¼Ó¼°²¡³ÌµÄÔö³¤Æä¸ßѪѹÊÓÍøÄ¤²¡±äµÄ»¼²¡ÂÊ´æÔÚÔö¼ÓµÄÇ÷ÊÆ£¬ÕâÓëËæ×ÅÄêÁäÔö¼Ó¸ßѪѹ²¡²¡»¼²¡ÂÊÖð½¥Ôö¸ß[10]ÏàÒ»Ö¡£±¾µ÷²é½á¹û±íÃ÷Ëæ×Å»¼ÕßÄêÁäÔö¼Ó¸ßѪѹÊÓÍøÄ¤²¡±ä»¼²¡ÂÊÖð½¥Ôö¼Ó£¬¿ÉÄÜÓëËæ×ÅÄêÁäµÄÔö¼Ó£¬»¼Õ߸ßѪѹµÄ²¡³ÌÏà¶Ô½Ï³¤£¬Í¬Ê±¸ßѪѹµÄ³Ì¶ÈÏà¶ÔÔö³¤Óйء£ÓÐÑо¿ËµÃ÷¸ßѪѹ»¼ÕßÊÓÍøÄ¤µÄ¸Ä±äÓëÆäÊæÕÅѹÉý¸ß¹ØÏµ¸üΪÃÜÇÐ[9] £¬±¾´Îµ÷²é·¢ÏÖ1086Ãû¸ßѪѹ»¼ÕßÖÐ102ÀýΪµ¥´¿ÊæÕÅѹÉý¸ß»¼Õߣ¬ÆäÖÐÓÐ49Àý³öÏÖ¸ßѪѹÊÓÍøÄ¤²¡±ä£¬»¼²¡ÂÊΪ48.04%£¬¶ø234Àýµ¥´¿ÊÕËõѹÉý¸ßµÄ»¼ÕßÖÐ64Àý³öÏÖ¸ßѪѹÊÓÍøÄ¤²¡±ä£¬Æä»¼²¡ÂÊΪ27.35%£¬ÓÉ´ËÒ²¿ÉÒÔ¿´³öÊæÕÅѹÔÚ¸ßѪѹÊÓÍøÄ¤²¡±ä·¢Éú¹ý³ÌÖÐ×÷Óøü´ó¡£ÊæÕÅѹ¸ß×îÖ±½ÓµÄÒòËØÊÇÍâÖÜѪ¹ÜµÄ×èÁ¦Ôö¸ß£¬´ÓijÖÖÒâÒåÉÏ˵±È¸ßѹ¸ß¸üΣÏÕ, ÓÐÁÙ´²×ÊÁϱíÃ÷£¬ÊæÕÅѹµÄ¸ßµÍÓëÐÄÄÔѪ¹Ü²¢·¢Ö¢ÓÐÃÜÇйØÏµ£¬Èç¹ûÊÕËõѹÕý³££¬ÄÇÃ´ÊæÕÅѹΪ70¡«75mmHgµÄÈË£¬ÓëÊæÕÅѹΪ 105¡«110mmHgµÄÈ˱Ƚϣ¬ºóÕß·¢ÉúÐÄÄÔѪ¹Ü²¢·¢Ö¢µÄ¸ÅÂʿɸ߳ö3¡«5±¶£¬Òò´Ë£¬ÊæÕÅѹÔö¸ßÓ¦¸ÃÒýÆð×ã¹»µÄÖØÊÓ¡£ ¡¡¡¡¡¡±¾Ñо¿ÖÐ1086Ãû¸ßѪѹ»¼ÕßÖУ¬79.1%µÄ»¼ÕßÖªµÀ×Ô¼º»¼¸ßѪѹ²¡±äµ«½öÓÐ31. 5%µÄ»¼ÕßÔø¾½ÓÊܹýÒ©ÎïÖÎÁÆ£¬¶ø¾ø´ó²¿·Ö»¼Õß²¢²»ÖªÏþÔÚÒ»¶¨Çé¿öϸßѪѹ¿ÉÒÔʹÊÓÁ¦Ï½µ£¬ËµÃ÷Ñо¿ÈËȺµÄÒ½ÁƱ£½¡Òâʶ²î£¬²»»áÖ÷¶¯È¥Ò½Ôº×÷½¡¿µÌå¼ì£¬¶øÇÒÔÚÉÙÊý½ÓÊÜÖÎÁƵϼÕßÖзþÒ©´øÓкܴóµÄËæÒâÐÔºÍäĿÐÔ£¬·þÒ©ÆÚ¼ä²»¼à²âѪѹ£¬²»ÄÑÊܲ»·þÒ©£¬ÑªÑ¹Õý³£¾ÍÍ£Ò©£¬°´¹ã¸æ»òÇ×ÅóºÃÓѵĽéÉÜ·þÒ©£¬¶ø²»°´Ò½Öö·þÒ©µÈ¡£ ¡¡¡¡¡¡ÁíÒ»·½Ãæ´Ë´Îµ÷²éÏÔʾ¸ßѪѹÊÓÍøÄ¤²¡±ä»¼ÕߢñÆÚ¡¢¢òÆÚ¡¢¢óÆÚ»¼²¡¹¹³É±ÈΪ67.82%£¬22.60%¼°9.58%£¬Ã»Óз¢ÏÖ¢ôÆÚ»¼Õߣ¬½öÓÐÉÙÊýÈ˳öÏֱȽÏÑÏÖØµÄÑÛ²¿²¢·¢Ö¢£¬ÇÒÒÔÇá¶Èµ½ÖжȲ¡±äÕ߾Ӷ࣬ËùÒÔÈç¹ûÊʵ±µÄ½øÐÐÐû½Ì£¬¼ÓÇ¿¸ßѪѹÉçÇø·ÀÖι¤×÷£¬¹æ·¶¹ÜÀí£¬Ìá¸ßÈËÃǶÔÓÚ¸ßѪѹÒÔ¼°¸ßѪѹÊÓÍøÄ¤²¡±äµÄÈÏʶ£¬Ê¹Æä¼°Ê±¾ÍÕ ¶¨ÆÚ²âÁ¿ÑªÑ¹¡¢ºÏÀíÓÃÒ©£¬¹æ·¶ÖÎÁÆ£¬¾ÍÄܹ»ºÜºÃµÄÔ¤·ÀÑÏÖØ²¢·¢Ö¢µÄ³öÏÖ£¬ÓÐЧ¼õÉÙ»¼ÕßäµÄ³öÏÖ£¬Ìá¸ßÆäÉú»îÖÊÁ¿£¬¼õÇáÆä¾¼Ã¸ºµ££¬ÕâÊǸÄÉÆÎÒ¹úÈËȺ¸ßѪѹ֪ÏþÂÊ¡¢ÖÎÁÆÂʺͿØÖÆÂʵĸù±¾¡£ËùÒÔÑÛ¿ÆÒ½Ê¦ÐèҪͬÉçÇø¡¢»ù²ãÒ½ÁÆ»ú¹¹ÒÔ¼°¸÷¼¶ÎÀÉú¹ÜÀí»ú¹¹ÔÚ²»Í¬²ãÃæÉϵÄÃÜÇÐÐ×÷½¨Á¢¸ßѪѹÊÓÍøÄ¤²¡±äµÄÁ¢Ìå·ÀÖÎÌåϵ¡£ ¡¡¡¡¡¡ ²Î¿¼ÎÄÏ× [1]Wong TY,Klein R,Klein BE,etal.Retinal microvascular abnormalities and their relationship with hypertension ,cardivascular disease and mortality[J]. Surv Ophthalmol 2001,46(1):59-80. [2]Born BJ, Hulaman CA, Hoekstra JB,et al.Value of routine funduscopy in patients with hypertension systematic review[J].BMJ 2005,331:73-76. [3] Wong TY, Mitchell P.Hypertensive retinopathy[J].N Engl Med,2004,351:2310-2317. [4] Wong TY.Is retinal photography useful in the measurement of stroke risk? [J]Lancet Neurol,2004,3:179-183. [5] Öйú¸ßѪѹ·ÀÖÎÖ¸ÄÏÐÞ¶©Î¯Ô±»á. 2004ÄêÖйú¸ßѪѹ·ÀÖÎÖ¸ÄÏ[J]. ¸ßѪѹÔÓÖ¾, 2004, 12( 2) : 483- 486. [6]¡¡ÁÎÊ÷É. ¸ßѪѹ²¡ÑÛµ×Õï¶Ïѧ[M ]. Î÷°²:ÉÂÎ÷¿ÆÑ§¼¼Êõ³ö°æÉç, 1990, 51. [7]ÕųзÒ.1000ÀýÔÎÒÐÔ¸ßѪѹ²¡È˵ÄÑÛµ×¹Û²ì²ì¼°ÆäÁÙ´²·ÖÎö. [J]ÖлªÒ½Ñ§ÔÓÖ¾£¬1960£¬4£º272-277. [8] 1000Àý¸ßѪѹ²¡µÄÑÛµ×¹Û²ì.[J]ÖлªÑÛ¿ÆÔÓ.1965,12:489-494. [9]½ªÊçÓ¢,Éлۣ¬Ö£µÂÔ£.Ô·¢ÐÔ¸ßѪѹ600ÀýÑÛµ×±íÏÖÁÙ´²·ÖÎö£¬[J]ÃÀÖйú¼ÊÑÛ¿ÆÔÓÖ¾£¬2002£¬2£¨1£©£¬37-38. [10]ÓÚÖ¾¸Õ £¬ÕÅ´º£¬Íõº£Æ½µÈ.ɽ¶«À³ÖݸßѪѹ²¡Á÷Ðв¡Ñ§µ÷²é£¬[J]Ϋ·»Ò½Ñ§Ôº±¨2006Ä꣬ 28£¨4£©£¬295-296. |
» ²ÂÄãϲ»¶
߹ळÈȾɫ pH Ëá
ÒѾÓÐ0È˻ظ´
ÇëÎʹØÓÚ²©ºó»ù½ðÆÀÉó˫äµÄÀí½â
ÒѾÓÐ23È˻ظ´
¿ÚÇ»Âò¢Ãæ¿ÆÑ§ÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ282È˻ظ´
²©ºóÃæÉϺÍÕ¾ÖÐÌØÖú£¬ÆÀÉóר¼Òµ½µ×Äܲ»ÄÜ¿´µ½ÉêÇëÈË·¢±í³É¹ûÇé¿ö£¿
ÒѾÓÐ23È˻ظ´
¸öÈËϵͳ²éÖÐûÖУ¬¿Éͨ¹ý¹ú¼ÊºÏ×÷ÑéÖ¤£¨ºÜ׼ȷ£©
ÒѾÓÐ111È˻ظ´
MOF¿×µÀ´¹Ö±Éú³¤ÔÚ¾ÛºÏÎï»ùµ×ÉÏ
ÒѾÓÐ0È˻ظ´
¸ÃÌùĿǰÒÑÕÐÊÕµ½×ã¹»ÊýÁ¿µÄºòÑ¡Õß¡£¸Ðл´ó¼ÒµÄ¹Ø×¢£¬×£ºÃÔË£¡
ÒѾÓÐ4È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
ҽѧͳ¼ÆÑ§Êý¾Ý·ÖÎöÎÊÌâ
ÒѾÓÐ4È˻ظ´
ͳ¼ÆÒ»Ï·ÖÎö·½ÏòµÄÅóÓÑÓÐûÓÐȥҽѧ²¿Ò©Îïѧ--Ò©Îï·ÖÎö·½ÏòÉêÇë¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðµÄ£¿
ÒѾÓÐ52È˻ظ´
Çë°ïæ·ÖÎöÖ±³¦°©²¡Çé¼°ºó¼ÌÖÎÁÆ·½°¸
ÒѾÓÐ7È˻ظ´
°ïæÏÂÔØ¡¶ÂÞÊÏMODULEP800Éú»¯·ÖÎöÒǶ¨±ê¹ÊÕϼìÐÞ ¡·
ÒѾÓÐ3È˻ظ´
¡¾ÇóÖú¡¿Ò½Ñ§Í³¼ÆÑ§µÄÎÊÌ⣬°ï棬лл
ÒѾÓÐ7È˻ظ´
¡¾×ÊÔ´¡¿Ò½Ñ§Í³¼Æ·ÖÎö·þÎñ·ÖÏí
ÒѾÓÐ3È˻ظ´

carofe
Ìú³æ (СÓÐÃûÆø)
- Ó¦Öú: 1 (Ó×¶ùÔ°)
- ½ð±Ò: 151.1
- Ìû×Ó: 80
- ÔÚÏß: 14.2Сʱ
- ³æºÅ: 2062589
- ×¢²á: 2012-10-15
- ÐÔ±ð: GG
- רҵ: ÄÔ¹¦Äܱ£»¤¡¢ÖÎÁÆÓ뿵¸´

2Â¥2012-10-30 18:25:28














»Ø¸´´ËÂ¥